Search

everythinglearnresearchcommunity

for

Search:↓

How bad a woman's hair loss is doesn't always match how it affects her happiness and daily life.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

The document says there are five types of hair loss conditions and different causes, including drugs.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

The dietary supplement helped increase hair growth in women with hair loss.

Trichodynia found in 29% of TE or AGA patients, linked to psychological conditions.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

COVID-19 may cause hair loss due to infection stress or treatments.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

A dietary supplement with Boswellia serrata, Curcuma longa, and Vitis vinifera showed potential improvement in hair health for telogen effluvium patients, but more research is needed.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Personality traits and anxiety affect hair loss patients' quality of life.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

Taking zinc supplements can help improve or cure hair loss caused by zinc deficiency.

Scalp pain is a common symptom in people with active hair loss from telogen effluvium.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

COVID-19 may cause temporary hair loss in some people.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.